Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II double-blind, placebo-controlled dose-finding study of mirtazapine in depressed patients
jRCT2080222778Phase 2
- Sponsor
- Meiji Seika Pharma Co., Ltd.
- Start
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of mirtazapine in major depressive disorder (MDD) (4 arms), sponsored by Meiji Seika Pharma Co., Ltd.
02
Drugs
mirtazapine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on jRCT2080222778.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222778.